The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022

Overview

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022 provides an extensive review of contemporary topics in hematology and oncology. This on-demand course covers molecular biology, diagnostic approaches, management strategies, and emerging therapies across various malignancies and hematologic disorders, supporting clinical proficiency and knowledge reinforcement.

On-demand oncology and hematology education — accessible anytime, anywhere.

Agenda

This comprehensive update consists of a wide range of expert-led presentations addressing key clinical and scientific advances in hematology and oncology. The agenda includes:

• Molecular Genetics of Cancer — Nikhil Wagle, MD
• Advances in Cancer Drug Development Part I – Chemotherapy and Targeted Agents — Geoffrey I. Shapiro, MD, PhD
• Advances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment — Geoffrey I. Shapiro, MD, PhD
• Infections in Cancer Patients — Lindsey Baden, MD
• Symptom Management in Patients with Cancer — Andrew J. Lawton, MD
• Communication: The Key to Excellence in End-of-Life Care — Rachelle E. Bernacki, MD
• Biology of Hematopoietic Stem Cell Transplantation — Robert J. Soiffer, MD
• Biology of Acute Leukemia and Myelodysplastic Syndromes — Benjamin L. Ebert, MD, PhD
• Acute Leukemias — Daniel J. DeAngelo, MD, PhD
• Myelodysplastic Syndrome — Eric S. Winer, MD
• Chronic Myelogenous Leukemia — Marlise R. Luskin, MD
• Myeloproliferative Syndromes — Ann M. Mullally, MD
• Multiple Myeloma — Kenneth C. Anderson, MD
• Waldenstrom Macroglobulemia and Amyloidosis — Jorge Castillo, MD
• Low Grade Lymphomas — Caron A. Jacobson, MD
• Aggressive Non-Hodgkin Lymphoma — Eric Jacobsen, MD
• Hodgkin’s Lymphoma — Reid W. Merryman, MD
• Diagnosis and Treatment of CLL and Related B Cell Malignancies — Matthew S. Davids, MD
• Head and Neck Cancer — Robert I. Haddad, MD
• Natural History, Screening, and Small Cell Lung Cancer — Bruce E. Johnson, MD
• Non Small Cell Lung Cancer – Part 1 — Mark Awad, MD, PhD
• Non Small Cell Lung Cancer – Part 2 — Mark Awad, MD, PhD
• Mesothelioma and Thymoma — David M. Jackman, MD
• Carcinoid and Neuroendocrine Tumors — Jennifer Ang Chan, MD
• Novel Approaches for the Management of Esophageal and Gastric Cancers — Peter C. Enzinger, MD
• Pancreatic Cancer — Brian M. Wolpin, MD
• Hepatobiliary Cancer — James M. Cleary, MD, PhD
• Anal Cancer & Colorectal Cancers Part 1 — Robert J. Mayer, MD
• Colorectal Cancers Part 2 — Robert J. Mayer, MD
• Gastrointestinal Cancer: Genetic Syndromes — Matthew Yurgelun, MD
• Testicular Cancer — Mark M. Pomerantz, MD
• Renal and Bladder Cancer — Guru P. Sonpavde, MBBS
• Prostate Cancer Part I: Overview and Management of Localized Disease — Atish Choudhury, MD, PhD
• Prostate Cancer Part II: Management of Disseminated Prostate Cancer — Atish Choudhury, MD, PhD
• Melanoma — F. Stephen Hodi, MD
• Sarcomas and Gastrointestinal Stromal Tumors (GIST) — Suzanne George, MD
• Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer — Ursula A. Matulonis, MD
• Cervical and Endometrial Cancer — Panagiotis A. Konstantinopoulos, MD, PhD
• Neuro-oncology — David A. Reardon, MD
• Breast Cancer – Risk Factors, Genetics, Screening, and Prevention — Judy E. Garber, MD, MPH
• Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation — Harold J. Burstein, MD, PhD
• Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy — Harold J. Burstein, MD, PhD
• Management of Metastatic Breast Cancer — Adrienne G. Waks, MD
• Breast Cancer Survivorship — Ann H. Partridge, MD, MPH
• Hematopoiesis and Cytokines — David T. Scadden, MD
• Acquired Bone Marrow Failure — Julie-Aurore Losman, MD, PhD
• Congenital Bone Marrow Failure — Akiko Shimamura, MD, PhD
• Hemophagocytic Syndromes and Related Immunodeficiencies — Barbara A. Degar, MD
• Anemia – An Overview — Robert Stern, MD
• Iron Deficiency and Iron Overload — Mark D. Fleming, MD, Dphil
• Immune Hemolytic Anemia — Richard M. Kaufman, MD
• Non-immune Hemolytic Anemia — David E. Golan, PhD, MD
• Sickle Cell Disease — Maureen M. Achebe, MD, MPH
• Thalassemia and Other Hemoglobinopathies — Matthew M. Heeney, MD
• Disorders of Neutrophils — Nancy Berliner, MD
• Acquired Thrombocytopenias — Elisabeth M. Battinelli, MD, PhD
• Hemophilia — Aric D. Parnes, MD
• Von Willebrand Disease and Congenital Platelet Disorders — Nathan T. Connell, MD, MPH
• Congenital and Acquired Thrombophilia — Kenneth A. Bauer, MD
• Use of Direct Oral Anticoagulants in Clinical Practice — Jean M. Connors, MD
• Transfusion Medicine for the Clinician — Walter H. Dzik, MD

Speakers

• Nikhil Wagle, MD
• Geoffrey I. Shapiro, MD, PhD
• Lindsey Baden, MD
• Andrew J. Lawton, MD
• Rachelle E. Bernacki, MD
• Robert J. Soiffer, MD
• Benjamin L. Ebert, MD, PhD
• Daniel J. DeAngelo, MD, PhD
• Eric S. Winer, MD
• Marlise R. Luskin, MD
• Ann M. Mullally, MD
• Kenneth C. Anderson, MD
• Jorge Castillo, MD
• Caron A. Jacobson, MD
• Eric Jacobsen, MD
• Reid W. Merryman, MD
• Matthew S. Davids, MD
• Robert I. Haddad, MD
• Bruce E. Johnson, MD
• Mark Awad, MD, PhD
• David M. Jackman, MD
• Jennifer Ang Chan, MD
• Peter C. Enzinger, MD
• Brian M. Wolpin, MD
• James M. Cleary, MD, PhD
• Robert J. Mayer, MD
• Matthew Yurgelun, MD
• Mark M. Pomerantz, MD
• Guru P. Sonpavde, MBBS
• Atish Choudhury, MD, PhD
• F. Stephen Hodi, MD
• Suzanne George, MD
• Ursula A. Matulonis, MD
• Panagiotis A. Konstantinopoulos, MD, PhD
• David A. Reardon, MD
• Judy E. Garber, MD, MPH
• Harold J. Burstein, MD, PhD
• Adrienne G. Waks, MD
• Ann H. Partridge, MD, MPH
• David T. Scadden, MD
• Julie-Aurore Losman, MD, PhD
• Akiko Shimamura, MD, PhD
• Barbara A. Degar, MD
• Robert Stern, MD
• Mark D. Fleming, MD, Dphil
• Richard M. Kaufman, MD
• David E. Golan, PhD, MD
• Maureen M. Achebe, MD, MPH
• Matthew M. Heeney, MD
• Nancy Berliner, MD
• Elisabeth M. Battinelli, MD, PhD
• Aric D. Parnes, MD
• Nathan T. Connell, MD, MPH
• Kenneth A. Bauer, MD
• Jean M. Connors, MD
• Walter H. Dzik, MD

Target Audience

This course is designed for hematologists, oncologists, internal medicine physicians, advanced practice providers, fellows, and other healthcare professionals involved in the diagnosis, management, and treatment of hematologic and oncologic conditions seeking to update their clinical knowledge and enhance expertise in current standards of care.

Why This Topic Matters

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022 addresses essential advances and clinical challenges within hematology and oncology. This resource supports healthcare professionals in maintaining up-to-date knowledge that is critical for informed patient management in these complex specialties.

Presented through MedHub Central, this on-demand educational offering facilitates ongoing professional development by providing accessible content that strengthens clinical judgment and confidence in applying evolving therapeutic strategies.